NCT06185647View on ClinicalTrials.gov

Evaluation in Practice of the Impact of NIrsevimab on EmeRgency Use for BRONCHIOlitis

CompletedOBSERVATIONAL
Enrollment

4,924

Participants

Timeline

Start Date

October 14, 2023

Primary Completion Date

February 29, 2024

Study Completion Date

February 29, 2024

Conditions
BronchiolitisRespiratory Syncytial Virus (RSV)Immunization; Infection
Interventions
OTHER

No intervention. Observational retrospective study

No intervention.

Trial Locations (1)

75012

Hôpital Armand Trousseau, Paris

All Listed Sponsors
lead

Hôpital Armand Trousseau

OTHER

NCT06185647 - Evaluation in Practice of the Impact of NIrsevimab on EmeRgency Use for BRONCHIOlitis | Biotech Hunter | Biotech Hunter